摘要
目的探讨血管紧张素(1-7)[Ang-(1-7)]阻断血管紧张素Ⅱ(AngⅡ)致炎作用的可能机制。方法原代培养人脐静脉内皮细胞,取2-5代用于实验。培养细胞随机分两组:Ⅰ组:对照组,AngⅡ组和AngⅡ+不同浓度Ang(1-7)组;Ⅱ组:对照组,AngⅡ组,Ang(1-7)组,AngⅡ+Ang-(1-7)组,AngⅡ+Ang(1-7)+A-779组,A-779组。用免疫印迹法测定细胞p38MAPK磷酸化表达。培养细胞用RT-PCR法测定Ang(1-7)的特异性受体M as受体的表达。结果 100 nmol/L Ang(1-7)可以拮抗100 nmol/L AngⅡ诱导的人脐静脉内皮细胞p38MAPK磷酸化表达,且呈剂量依赖性。随着Ang(1-7)剂量的增加p38MAPK磷酸化表达逐渐减弱,在1000 nmol/L Ang(1-7)时即有明显减弱。Ang(1-7)受体特异性拮抗剂A-779可显著抑制Ang(1-7)的此作用。结论 Ang(1-7)呈剂量依赖性拮抗AngⅡ激活人脐静脉内皮细胞p38MAPK通路的作用。
Aim To study the effect of angiotensin(1-7) on inhibiting the inflammation induced by angiotensinⅡ(AngⅡ).Methods Cultured human umbilical vein endothelial cells(HUVEC) were randomly dividied into different groups,then incubated in the presence of Ang(1-7),AngⅡ and the specific inhibitor of Ang(1-7),A-779,and so on.The phosphorylation of p38MAPK were determined by Western blot,and the mRNA for the mas receptor were determined by reverse transcriptional PCR. Results Ang(1-7) dose-dependently inhibited the phosphorylation of p38MAPK induced by AngⅡ in HUVECs.The expression of p38MAPK phosphorylation died down markedly at 1 000 nmol/L of Ang(1-7).Pre-treatment with A-779 for 10 min in HUVEC before Ang(1-7) and AngⅡ used,the expression of p38 MAPK phosphorylation was nonsignificantly changed. Conclusion Ang(1-7) effectively represses the phosphorylation of p38MAPK induced by AngⅡ in HUVEC.
出处
《中国动脉硬化杂志》
CAS
CSCD
北大核心
2011年第1期39-43,共5页
Chinese Journal of Arteriosclerosis